oxazoles has been researched along with orlistat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Smidt, PC; Rades, T | 1 |
| Dirat, O; Kouklovsky, C; Langlois, Y | 1 |
| Barthel, B; Koch, TH; Shi, D; Xiao, D; Yan, B; Yang, D | 1 |
3 other study(ies) available for oxazoles and orlistat
| Article | Year |
|---|---|
Direct detection of dissolution of 14C-labeled compounds into an oil phase by the fat scintillation proximity method.
Topics: Carbon Radioisotopes; Crystallization; Lactones; Oils; Olive Oil; Orlistat; Oxazoles; Plant Oils; Powders; Scintillation Counting; Solubility; Styrenes | 2000 |
Oxazoline N-oxide-mediated [2+3] cycloadditions. Application to a synthesis of (-)-tetrahydrolipstatin.
Topics: Aldehydes; Cyclization; Hydrolysis; Indicators and Reagents; Lactones; Magnetic Resonance Spectroscopy; Orlistat; Oxazoles; Oxidation-Reduction | 1999 |
Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs.
Topics: Animals; Anti-Obesity Agents; Antineoplastic Agents; Camptothecin; Carboxylic Ester Hydrolases; Cell Line; Cell Survival; Doxorubicin; Drug Interactions; Female; Humans; Irinotecan; Lactones; Liver; Male; Mice; Orlistat; Oxazoles; Prodrugs; Rats; Species Specificity | 2013 |